Erol Akgul1, Hasan Bilen Onan2, Irem Islek3, Mehmet Tonge4, Yavuz Durmus5, Mehmet Barburoglu6, Aynur Azizova7, Cengiz Erol3, Bahattin Hakyemez8, Serra Sencer6, Kubilay Aydin6,9, Anil Arat7. 1. Interventional Neuroradiology Section, Radiology Department, International School of Medicine, Istanbul Medipol University, Istanbul, Turkey. 2. Radiology Department, School of Medicine, Cukurova University, Adana, Turkey. 3. Radiology Department, School of Medicine, Istanbul Medipol University, Istanbul, Turkey. 4. Neurosurgery Department, School of Medicine, Istanbul Medipol University, Istanbul, Turkey. 5. Radiology Department, Bursa Yuksek Ihtisas Education and Research Hospital, Bursa, Turkey. 6. Department of Neuroradiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. 7. Radiology Department, School of Medicine, Hacettepe University, Ankara, Turkey. 8. Radiology Department, School of Medicine, Uludag University, Bursa, Turkey. 9. Department of Interventional Neuroradiology, Faculty of Medicine, Koc University, Istanbul, Turkey.
Abstract
BACKGROUND: We assessed the safety and efficacy of flow diverter stents (FDSs) in the treatment of recanalized or residual intracranial aneurysms treated endovascularly. MATERIALS & METHODS: Patients whose recanalized or residual aneurysms were treated with FDSs in five tertiary hospitals were reviewed retrospectively. The patients' demographic data, aneurysm characteristics, types of previous treatment, and clinical complications, or serious adverse events associated with FDSs, as well as the results of neurological and angiographic follow-up assessments, were recorded. RESULTS: Eighty-six patients (37 males) with 87 aneurysms were included in this study. Eighty (91.9%) aneurysms were in the anterior and seven (8.1%) in the posterior circulation. The initial treatment methods were the primary coiling or balloon remodeling technique in 69 (79.3%) and stent-assisted coiling in 18 (20.7%) aneurysms. The endovascular procedure was successful in all patients. Complications occurred in four patients, for a total complication rate of 4.6%. A technical complication developed in one patient (1.2%). An in-stent thrombosis treated with tirofiban was seen in two cases. Late in-stent stenosis exceeding 50% was treated with balloon angioplasty in one patient. The mean length of follow-up was 21.0 months. The first angiographic follow-up (3-6 months) revealed the complete occlusion of 74 aneurysms (85.1%). While 76 aneurysms (87.4%) were occluded at the last angiographic follow-up (mean: 26.0 months), 11 aneurysms (12.6%) were still filling. Morbimortality was zero. CONCLUSION: The drawback of endovascular treatment is aneurysmal remnants or recurrences, which is safely and durably amenable to flow diversion.
BACKGROUND: We assessed the safety and efficacy of flow diverter stents (FDSs) in the treatment of recanalized or residual intracranial aneurysms treated endovascularly. MATERIALS & METHODS: Patients whose recanalized or residual aneurysms were treated with FDSs in five tertiary hospitals were reviewed retrospectively. The patients' demographic data, aneurysm characteristics, types of previous treatment, and clinical complications, or serious adverse events associated with FDSs, as well as the results of neurological and angiographic follow-up assessments, were recorded. RESULTS: Eighty-six patients (37 males) with 87 aneurysms were included in this study. Eighty (91.9%) aneurysms were in the anterior and seven (8.1%) in the posterior circulation. The initial treatment methods were the primary coiling or balloon remodeling technique in 69 (79.3%) and stent-assisted coiling in 18 (20.7%) aneurysms. The endovascular procedure was successful in all patients. Complications occurred in four patients, for a total complication rate of 4.6%. A technical complication developed in one patient (1.2%). An in-stent thrombosis treated with tirofiban was seen in two cases. Late in-stent stenosis exceeding 50% was treated with balloon angioplasty in one patient. The mean length of follow-up was 21.0 months. The first angiographic follow-up (3-6 months) revealed the complete occlusion of 74 aneurysms (85.1%). While 76 aneurysms (87.4%) were occluded at the last angiographic follow-up (mean: 26.0 months), 11 aneurysms (12.6%) were still filling. Morbimortality was zero. CONCLUSION: The drawback of endovascular treatment is aneurysmal remnants or recurrences, which is safely and durably amenable to flow diversion.
Authors: Daniel M Heiferman; Joshua T Billingsley; Manish K Kasliwal; Andrew K Johnson; Kiffon M Keigher; Michel E Frudit; Roham Moftakhar; Demetrius K Lopes Journal: J Neurointerv Surg Date: 2015-06-03 Impact factor: 5.836
Authors: Anna Luisa Kühn; Katyucia de Macedo Rodrigues; J Diego Lozano; David E Rex; Francesco Massari; Takamitsu Tamura; Mary Howk; Christopher Brooks; Jenna L'Heureux; Matthew J Gounis; Ajay K Wakhloo; Ajit S Puri Journal: J Neurointerv Surg Date: 2016-11-25 Impact factor: 5.836
Authors: F Cagnazzo; D Mantilla; A Rouchaud; W Brinjikji; P-H Lefevre; C Dargazanli; G Gascou; C Riquelme; P Perrini; D di Carlo; A Bonafe; V Costalat Journal: AJNR Am J Neuroradiol Date: 2018-03-15 Impact factor: 3.825
Authors: A Rizvi; S M Seyedsaadat; M Alzuabi; M H Murad; R Kadirvel; W Brinjikji; D F Kallmes Journal: AJNR Am J Neuroradiol Date: 2020-05-28 Impact factor: 3.825
Authors: Nohra Chalouhi; Pascal Jabbour; Saurabh Singhal; Ross Drueding; Robert M Starke; Richard T Dalyai; Stavropoula Tjoumakaris; L Fernando Gonzalez; Aaron S Dumont; Robert Rosenwasser; Ciro G Randazzo Journal: Stroke Date: 2013-03-19 Impact factor: 7.914
Authors: Ricardo A Hanel; David F Kallmes; Demetrius Klee Lopes; Peter Kim Nelson; Adnan Siddiqui; Pascal Jabbour; Vitor M Pereira; Istvan Szikora István; Osama O Zaidat; Chetan Bettegowda; Geoffrey P Colby; Maxim Mokin; Clemens Schirmer; Frank R Hellinger; Curtis Given Ii; Timo Krings; Philipp Taussky; Gabor Toth; Justin F Fraser; Michael Chen; Ryan Priest; Peter Kan; David Fiorella; Don Frei; Beverly Aagaard-Kienitz; Orlando Diaz; Adel M Malek; C Michael Cawley; Ajit S Puri Journal: J Neurointerv Surg Date: 2019-07-15 Impact factor: 5.836